Global Drugs for Schistosomiasis Supply, Demand and Key Producers, 2026-2032
The global Drugs for Schistosomiasis market size is expected to reach $ 121 million by 2032, rising at a market growth of 3.7% CAGR during the forecast period (2026-2032).
Drugs for Schistosomiasis are specialized antiparasitic medications used for the prevention and treatment of human schistosomiasis, caused by parasitic worms of the Schistosoma genus. These drugs function by disrupting the neuromuscular activity of the parasite, inhibiting its metabolism and reproduction, thereby killing adult worms or preventing egg development. They are widely applied in endemic regions for mass prevention, acute infection treatment, and chronic disease management. Common drugs include praziquantel and other antischistosomal agents. Schistosomiasis drugs play a central role in public health control and tropical disease prevention, especially in large-scale community interventions and international aid programs. With advances in research and development, new drugs are evolving toward higher efficacy, safety, and low resistance to meet global schistosomiasis elimination strategies.In 2025, global Drugs for Schistosomiasis production reached approximately 1.52 billion units and price is about 60 USD/ K Units.The average gross profit margin of this product is 35%.
Schistosomiasis remains endemic in tropical and subtropical regions, and public health authorities and international organizations prioritize its control and elimination, providing stable long-term support for drug demand. The implementation of global health aid programs and large-scale mass drug administration (MDA) initiatives significantly boosts market penetration. Improved diagnostic capabilities and expanded infection surveillance allow more potential patients to receive timely intervention, sustaining ongoing demand. Advances in drug development technology enhance efficacy and safety, enabling existing products to cover diverse age groups and high-risk populations, thereby supporting overall market growth.
The drugs for schistosomiasis market faces key challenges including limited drug variety, resistance risks, and low-profit pressures. The heavy reliance on a few commonly used drugs may result in long-term resistance issues. Low-income markets constrain pricing and procurement systems, affecting industry profitability. Supply chain management involves API production, drug packaging, and distribution to remote endemic areas, where logistical and storage instability may limit accessibility. Policy changes and adjustments in international aid funding can also introduce market volatility risks.
Downstream demand primarily comes from public health institutions, local health departments, and international aid programs. Mass preventive treatment exhibits stability and seasonal characteristics, with children and adolescents in high-risk areas as the main recipients. With more precise epidemiological monitoring and infection mapping, drug distribution becomes more targeted, supporting customized supply strategies for specific regions and populations. Oral convenience and safety have become key factors in procurement decisions, driving formulation improvements toward oral tablets and easily dissolvable forms.
The core raw materials for schistosomiasis drugs mainly include the active pharmaceutical ingredients (APIs) and excipient systems. API quality directly determines drug efficacy and safety, especially the purity and stability of praziquantel and other antischistosomal compounds. Manufacturing involves solvents, stabilizers, fillers, and packaging materials needed for tablets or granule formulations. Upstream raw material supply is influenced by the global chemical and pharmaceutical raw material markets, with price and delivery cycle fluctuations. As production technology advances and quality management becomes standardized, the controllability and stability of raw materials are key factors in ensuring product quality and supply reliability.
This report studies the global Drugs for Schistosomiasis production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs for Schistosomiasis and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Schistosomiasis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drugs for Schistosomiasis total production and demand, 2021-2032, (M Units)
Global Drugs for Schistosomiasis total production value, 2021-2032, (USD Million)
Global Drugs for Schistosomiasis production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Drugs for Schistosomiasis consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Drugs for Schistosomiasis domestic production, consumption, key domestic manufacturers and share
Global Drugs for Schistosomiasis production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Drugs for Schistosomiasis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals, Endo International, Shenyang Hongqi Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs for Schistosomiasis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/K Units) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drugs for Schistosomiasis Market, By Region:
1. How big is the global Drugs for Schistosomiasis market?
2. What is the demand of the global Drugs for Schistosomiasis market?
3. What is the year over year growth of the global Drugs for Schistosomiasis market?
4. What is the production and production value of the global Drugs for Schistosomiasis market?
5. Who are the key producers in the global Drugs for Schistosomiasis market?
6. What are the growth factors driving the market demand?
Drugs for Schistosomiasis are specialized antiparasitic medications used for the prevention and treatment of human schistosomiasis, caused by parasitic worms of the Schistosoma genus. These drugs function by disrupting the neuromuscular activity of the parasite, inhibiting its metabolism and reproduction, thereby killing adult worms or preventing egg development. They are widely applied in endemic regions for mass prevention, acute infection treatment, and chronic disease management. Common drugs include praziquantel and other antischistosomal agents. Schistosomiasis drugs play a central role in public health control and tropical disease prevention, especially in large-scale community interventions and international aid programs. With advances in research and development, new drugs are evolving toward higher efficacy, safety, and low resistance to meet global schistosomiasis elimination strategies.In 2025, global Drugs for Schistosomiasis production reached approximately 1.52 billion units and price is about 60 USD/ K Units.The average gross profit margin of this product is 35%.
Schistosomiasis remains endemic in tropical and subtropical regions, and public health authorities and international organizations prioritize its control and elimination, providing stable long-term support for drug demand. The implementation of global health aid programs and large-scale mass drug administration (MDA) initiatives significantly boosts market penetration. Improved diagnostic capabilities and expanded infection surveillance allow more potential patients to receive timely intervention, sustaining ongoing demand. Advances in drug development technology enhance efficacy and safety, enabling existing products to cover diverse age groups and high-risk populations, thereby supporting overall market growth.
The drugs for schistosomiasis market faces key challenges including limited drug variety, resistance risks, and low-profit pressures. The heavy reliance on a few commonly used drugs may result in long-term resistance issues. Low-income markets constrain pricing and procurement systems, affecting industry profitability. Supply chain management involves API production, drug packaging, and distribution to remote endemic areas, where logistical and storage instability may limit accessibility. Policy changes and adjustments in international aid funding can also introduce market volatility risks.
Downstream demand primarily comes from public health institutions, local health departments, and international aid programs. Mass preventive treatment exhibits stability and seasonal characteristics, with children and adolescents in high-risk areas as the main recipients. With more precise epidemiological monitoring and infection mapping, drug distribution becomes more targeted, supporting customized supply strategies for specific regions and populations. Oral convenience and safety have become key factors in procurement decisions, driving formulation improvements toward oral tablets and easily dissolvable forms.
The core raw materials for schistosomiasis drugs mainly include the active pharmaceutical ingredients (APIs) and excipient systems. API quality directly determines drug efficacy and safety, especially the purity and stability of praziquantel and other antischistosomal compounds. Manufacturing involves solvents, stabilizers, fillers, and packaging materials needed for tablets or granule formulations. Upstream raw material supply is influenced by the global chemical and pharmaceutical raw material markets, with price and delivery cycle fluctuations. As production technology advances and quality management becomes standardized, the controllability and stability of raw materials are key factors in ensuring product quality and supply reliability.
This report studies the global Drugs for Schistosomiasis production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Drugs for Schistosomiasis and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Drugs for Schistosomiasis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Drugs for Schistosomiasis total production and demand, 2021-2032, (M Units)
Global Drugs for Schistosomiasis total production value, 2021-2032, (USD Million)
Global Drugs for Schistosomiasis production by region & country, production, value, CAGR, 2021-2032, (USD Million) & (M Units), (based on production site)
Global Drugs for Schistosomiasis consumption by region & country, CAGR, 2021-2032 & (M Units)
U.S. VS China: Drugs for Schistosomiasis domestic production, consumption, key domestic manufacturers and share
Global Drugs for Schistosomiasis production by manufacturer, production, price, value and market share 2021-2026, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Type, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
Global Drugs for Schistosomiasis production by Application, production, value, CAGR, 2021-2032, (USD Million) & (M Units)
This report profiles key players in the global Drugs for Schistosomiasis market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals, Endo International, Shenyang Hongqi Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Drugs for Schistosomiasis market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (M Units) and average price (US$/K Units) by manufacturer, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Drugs for Schistosomiasis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Praziquantel
- Oxamniquine
- Other
- Oral Tablets
- Oral Suspension
- Injectable Form
- Other
- Hospitals Use
- Pediatric Use
- NGO Programs
- S. haematobium
- S. mansoni
- S. japonicum
- S. mekongi
- S. intercalatum
- Shin Poong
- Merck
- Bayer
- EIPICO
- Chandra Bhagat Pharma
- Taj Pharmaceuticals
- Endo International
- Shenyang Hongqi Pharma
1. How big is the global Drugs for Schistosomiasis market?
2. What is the demand of the global Drugs for Schistosomiasis market?
3. What is the year over year growth of the global Drugs for Schistosomiasis market?
4. What is the production and production value of the global Drugs for Schistosomiasis market?
5. Who are the key producers in the global Drugs for Schistosomiasis market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Drugs for Schistosomiasis Introduction
1.2 World Drugs for Schistosomiasis Supply & Forecast
1.2.1 World Drugs for Schistosomiasis Production Value (2021 & 2025 & 2032)
1.2.2 World Drugs for Schistosomiasis Production (2021-2032)
1.2.3 World Drugs for Schistosomiasis Pricing Trends (2021-2032)
1.3 World Drugs for Schistosomiasis Production by Region (Based on Production Site)
1.3.1 World Drugs for Schistosomiasis Production Value by Region (2021-2032)
1.3.2 World Drugs for Schistosomiasis Production by Region (2021-2032)
1.3.3 World Drugs for Schistosomiasis Average Price by Region (2021-2032)
1.3.4 North America Drugs for Schistosomiasis Production (2021-2032)
1.3.5 Europe Drugs for Schistosomiasis Production (2021-2032)
1.3.6 China Drugs for Schistosomiasis Production (2021-2032)
1.3.7 Japan Drugs for Schistosomiasis Production (2021-2032)
1.3.8 India Drugs for Schistosomiasis Production (2021-2032)
1.3.9 South Korea Drugs for Schistosomiasis Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Schistosomiasis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs for Schistosomiasis Major Market Trends
2 DEMAND SUMMARY
2.1 World Drugs for Schistosomiasis Demand (2021-2032)
2.2 World Drugs for Schistosomiasis Consumption by Region
2.2.1 World Drugs for Schistosomiasis Consumption by Region (2021-2026)
2.2.2 World Drugs for Schistosomiasis Consumption Forecast by Region (2027-2032)
2.3 United States Drugs for Schistosomiasis Consumption (2021-2032)
2.4 China Drugs for Schistosomiasis Consumption (2021-2032)
2.5 Europe Drugs for Schistosomiasis Consumption (2021-2032)
2.6 Japan Drugs for Schistosomiasis Consumption (2021-2032)
2.7 South Korea Drugs for Schistosomiasis Consumption (2021-2032)
2.8 ASEAN Drugs for Schistosomiasis Consumption (2021-2032)
2.9 India Drugs for Schistosomiasis Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drugs for Schistosomiasis Production Value by Manufacturer (2021-2026)
3.2 World Drugs for Schistosomiasis Production by Manufacturer (2021-2026)
3.3 World Drugs for Schistosomiasis Average Price by Manufacturer (2021-2026)
3.4 Drugs for Schistosomiasis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drugs for Schistosomiasis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drugs for Schistosomiasis in 2025
3.5.3 Global Concentration Ratios (CR8) for Drugs for Schistosomiasis in 2025
3.6 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
3.6.1 Drugs for Schistosomiasis Market: Region Footprint
3.6.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
3.6.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison
4.1.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Drugs for Schistosomiasis Production Comparison
4.2.1 United States VS China: Drugs for Schistosomiasis Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Drugs for Schistosomiasis Consumption Comparison
4.3.1 United States VS China: Drugs for Schistosomiasis Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Drugs for Schistosomiasis Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drugs for Schistosomiasis Production Value (2021-2026)
4.4.3 United States Based Manufacturers Drugs for Schistosomiasis Production (2021-2026)
4.5 China Based Drugs for Schistosomiasis Manufacturers and Market Share
4.5.1 China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drugs for Schistosomiasis Production Value (2021-2026)
4.5.3 China Based Manufacturers Drugs for Schistosomiasis Production (2021-2026)
4.6 Rest of World Based Drugs for Schistosomiasis Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Drugs for Schistosomiasis Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs for Schistosomiasis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Praziquantel
5.2.2 Oxamniquine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Drugs for Schistosomiasis Production by Type (2021-2032)
5.3.2 World Drugs for Schistosomiasis Production Value by Type (2021-2032)
5.3.3 World Drugs for Schistosomiasis Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Drugs for Schistosomiasis Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Oral Tablets
6.2.2 Oral Suspension
6.2.3 Injectable Form
6.2.4 Other
6.3 Market Segment by Dosage Form
6.3.1 World Drugs for Schistosomiasis Production by Dosage Form (2021-2032)
6.3.2 World Drugs for Schistosomiasis Production Value by Dosage Form (2021-2032)
6.3.3 World Drugs for Schistosomiasis Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY END USER
7.1 World Drugs for Schistosomiasis Market Size Overview by End User: 2021 VS 2025 VS 2032
7.2 Segment Introduction by End User
7.2.1 Hospitals Use
7.2.2 Pediatric Use
7.2.3 NGO Programs
7.3 Market Segment by End User
7.3.1 World Drugs for Schistosomiasis Production by End User (2021-2032)
7.3.2 World Drugs for Schistosomiasis Production Value by End User (2021-2032)
7.3.3 World Drugs for Schistosomiasis Average Price by End User (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Drugs for Schistosomiasis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 S. haematobium
8.2.2 S. mansoni
8.2.3 S. japonicum
8.2.4 S. mekongi
8.2.5 S. intercalatum
8.3 Market Segment by Application
8.3.1 World Drugs for Schistosomiasis Production by Application (2021-2032)
8.3.2 World Drugs for Schistosomiasis Production Value by Application (2021-2032)
8.3.3 World Drugs for Schistosomiasis Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Shin Poong
9.1.1 Shin Poong Details
9.1.2 Shin Poong Major Business
9.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
9.1.4 Shin Poong Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Shin Poong Recent Developments/Updates
9.1.6 Shin Poong Competitive Strengths & Weaknesses
9.2 Merck
9.2.1 Merck Details
9.2.2 Merck Major Business
9.2.3 Merck Drugs for Schistosomiasis Product and Services
9.2.4 Merck Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Merck Recent Developments/Updates
9.2.6 Merck Competitive Strengths & Weaknesses
9.3 Bayer
9.3.1 Bayer Details
9.3.2 Bayer Major Business
9.3.3 Bayer Drugs for Schistosomiasis Product and Services
9.3.4 Bayer Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bayer Recent Developments/Updates
9.3.6 Bayer Competitive Strengths & Weaknesses
9.4 EIPICO
9.4.1 EIPICO Details
9.4.2 EIPICO Major Business
9.4.3 EIPICO Drugs for Schistosomiasis Product and Services
9.4.4 EIPICO Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 EIPICO Recent Developments/Updates
9.4.6 EIPICO Competitive Strengths & Weaknesses
9.5 Chandra Bhagat Pharma
9.5.1 Chandra Bhagat Pharma Details
9.5.2 Chandra Bhagat Pharma Major Business
9.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
9.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Chandra Bhagat Pharma Recent Developments/Updates
9.5.6 Chandra Bhagat Pharma Competitive Strengths & Weaknesses
9.6 Taj Pharmaceuticals
9.6.1 Taj Pharmaceuticals Details
9.6.2 Taj Pharmaceuticals Major Business
9.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
9.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Taj Pharmaceuticals Recent Developments/Updates
9.6.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
9.7 Endo International
9.7.1 Endo International Details
9.7.2 Endo International Major Business
9.7.3 Endo International Drugs for Schistosomiasis Product and Services
9.7.4 Endo International Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Endo International Recent Developments/Updates
9.7.6 Endo International Competitive Strengths & Weaknesses
9.8 Shenyang Hongqi Pharma
9.8.1 Shenyang Hongqi Pharma Details
9.8.2 Shenyang Hongqi Pharma Major Business
9.8.3 Shenyang Hongqi Pharma Drugs for Schistosomiasis Product and Services
9.8.4 Shenyang Hongqi Pharma Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Shenyang Hongqi Pharma Recent Developments/Updates
9.8.6 Shenyang Hongqi Pharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Drugs for Schistosomiasis Industry Chain
10.2 Drugs for Schistosomiasis Upstream Analysis
10.2.1 Drugs for Schistosomiasis Core Raw Materials
10.2.2 Main Manufacturers of Drugs for Schistosomiasis Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Drugs for Schistosomiasis Production Mode
10.6 Drugs for Schistosomiasis Procurement Model
10.7 Drugs for Schistosomiasis Industry Sales Model and Sales Channels
10.7.1 Drugs for Schistosomiasis Sales Model
10.7.2 Drugs for Schistosomiasis Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Drugs for Schistosomiasis Introduction
1.2 World Drugs for Schistosomiasis Supply & Forecast
1.2.1 World Drugs for Schistosomiasis Production Value (2021 & 2025 & 2032)
1.2.2 World Drugs for Schistosomiasis Production (2021-2032)
1.2.3 World Drugs for Schistosomiasis Pricing Trends (2021-2032)
1.3 World Drugs for Schistosomiasis Production by Region (Based on Production Site)
1.3.1 World Drugs for Schistosomiasis Production Value by Region (2021-2032)
1.3.2 World Drugs for Schistosomiasis Production by Region (2021-2032)
1.3.3 World Drugs for Schistosomiasis Average Price by Region (2021-2032)
1.3.4 North America Drugs for Schistosomiasis Production (2021-2032)
1.3.5 Europe Drugs for Schistosomiasis Production (2021-2032)
1.3.6 China Drugs for Schistosomiasis Production (2021-2032)
1.3.7 Japan Drugs for Schistosomiasis Production (2021-2032)
1.3.8 India Drugs for Schistosomiasis Production (2021-2032)
1.3.9 South Korea Drugs for Schistosomiasis Production (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Drugs for Schistosomiasis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Drugs for Schistosomiasis Major Market Trends
2 DEMAND SUMMARY
2.1 World Drugs for Schistosomiasis Demand (2021-2032)
2.2 World Drugs for Schistosomiasis Consumption by Region
2.2.1 World Drugs for Schistosomiasis Consumption by Region (2021-2026)
2.2.2 World Drugs for Schistosomiasis Consumption Forecast by Region (2027-2032)
2.3 United States Drugs for Schistosomiasis Consumption (2021-2032)
2.4 China Drugs for Schistosomiasis Consumption (2021-2032)
2.5 Europe Drugs for Schistosomiasis Consumption (2021-2032)
2.6 Japan Drugs for Schistosomiasis Consumption (2021-2032)
2.7 South Korea Drugs for Schistosomiasis Consumption (2021-2032)
2.8 ASEAN Drugs for Schistosomiasis Consumption (2021-2032)
2.9 India Drugs for Schistosomiasis Consumption (2021-2032)
3 WORLD MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Drugs for Schistosomiasis Production Value by Manufacturer (2021-2026)
3.2 World Drugs for Schistosomiasis Production by Manufacturer (2021-2026)
3.3 World Drugs for Schistosomiasis Average Price by Manufacturer (2021-2026)
3.4 Drugs for Schistosomiasis Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Drugs for Schistosomiasis Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Drugs for Schistosomiasis in 2025
3.5.3 Global Concentration Ratios (CR8) for Drugs for Schistosomiasis in 2025
3.6 Drugs for Schistosomiasis Market: Overall Company Footprint Analysis
3.6.1 Drugs for Schistosomiasis Market: Region Footprint
3.6.2 Drugs for Schistosomiasis Market: Company Product Type Footprint
3.6.3 Drugs for Schistosomiasis Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison
4.1.1 United States VS China: Drugs for Schistosomiasis Production Value Comparison (2021 & 2025 & 2032)
4.1.2 United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2021 & 2025 & 2032)
4.2 United States VS China: Drugs for Schistosomiasis Production Comparison
4.2.1 United States VS China: Drugs for Schistosomiasis Production Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2021 & 2025 & 2032)
4.3 United States VS China: Drugs for Schistosomiasis Consumption Comparison
4.3.1 United States VS China: Drugs for Schistosomiasis Consumption Comparison (2021 & 2025 & 2032)
4.3.2 United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2021 & 2025 & 2032)
4.4 United States Based Drugs for Schistosomiasis Manufacturers and Market Share, 2021-2026
4.4.1 United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Drugs for Schistosomiasis Production Value (2021-2026)
4.4.3 United States Based Manufacturers Drugs for Schistosomiasis Production (2021-2026)
4.5 China Based Drugs for Schistosomiasis Manufacturers and Market Share
4.5.1 China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Drugs for Schistosomiasis Production Value (2021-2026)
4.5.3 China Based Manufacturers Drugs for Schistosomiasis Production (2021-2026)
4.6 Rest of World Based Drugs for Schistosomiasis Manufacturers and Market Share, 2021-2026
4.6.1 Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value (2021-2026)
4.6.3 Rest of World Based Manufacturers Drugs for Schistosomiasis Production (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Drugs for Schistosomiasis Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Praziquantel
5.2.2 Oxamniquine
5.2.3 Other
5.3 Market Segment by Type
5.3.1 World Drugs for Schistosomiasis Production by Type (2021-2032)
5.3.2 World Drugs for Schistosomiasis Production Value by Type (2021-2032)
5.3.3 World Drugs for Schistosomiasis Average Price by Type (2021-2032)
6 MARKET ANALYSIS BY DOSAGE FORM
6.1 World Drugs for Schistosomiasis Market Size Overview by Dosage Form: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Dosage Form
6.2.1 Oral Tablets
6.2.2 Oral Suspension
6.2.3 Injectable Form
6.2.4 Other
6.3 Market Segment by Dosage Form
6.3.1 World Drugs for Schistosomiasis Production by Dosage Form (2021-2032)
6.3.2 World Drugs for Schistosomiasis Production Value by Dosage Form (2021-2032)
6.3.3 World Drugs for Schistosomiasis Average Price by Dosage Form (2021-2032)
7 MARKET ANALYSIS BY END USER
7.1 World Drugs for Schistosomiasis Market Size Overview by End User: 2021 VS 2025 VS 2032
7.2 Segment Introduction by End User
7.2.1 Hospitals Use
7.2.2 Pediatric Use
7.2.3 NGO Programs
7.3 Market Segment by End User
7.3.1 World Drugs for Schistosomiasis Production by End User (2021-2032)
7.3.2 World Drugs for Schistosomiasis Production Value by End User (2021-2032)
7.3.3 World Drugs for Schistosomiasis Average Price by End User (2021-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Drugs for Schistosomiasis Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 S. haematobium
8.2.2 S. mansoni
8.2.3 S. japonicum
8.2.4 S. mekongi
8.2.5 S. intercalatum
8.3 Market Segment by Application
8.3.1 World Drugs for Schistosomiasis Production by Application (2021-2032)
8.3.2 World Drugs for Schistosomiasis Production Value by Application (2021-2032)
8.3.3 World Drugs for Schistosomiasis Average Price by Application (2021-2032)
9 COMPANY PROFILES
9.1 Shin Poong
9.1.1 Shin Poong Details
9.1.2 Shin Poong Major Business
9.1.3 Shin Poong Drugs for Schistosomiasis Product and Services
9.1.4 Shin Poong Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.1.5 Shin Poong Recent Developments/Updates
9.1.6 Shin Poong Competitive Strengths & Weaknesses
9.2 Merck
9.2.1 Merck Details
9.2.2 Merck Major Business
9.2.3 Merck Drugs for Schistosomiasis Product and Services
9.2.4 Merck Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.2.5 Merck Recent Developments/Updates
9.2.6 Merck Competitive Strengths & Weaknesses
9.3 Bayer
9.3.1 Bayer Details
9.3.2 Bayer Major Business
9.3.3 Bayer Drugs for Schistosomiasis Product and Services
9.3.4 Bayer Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.3.5 Bayer Recent Developments/Updates
9.3.6 Bayer Competitive Strengths & Weaknesses
9.4 EIPICO
9.4.1 EIPICO Details
9.4.2 EIPICO Major Business
9.4.3 EIPICO Drugs for Schistosomiasis Product and Services
9.4.4 EIPICO Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.4.5 EIPICO Recent Developments/Updates
9.4.6 EIPICO Competitive Strengths & Weaknesses
9.5 Chandra Bhagat Pharma
9.5.1 Chandra Bhagat Pharma Details
9.5.2 Chandra Bhagat Pharma Major Business
9.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
9.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.5.5 Chandra Bhagat Pharma Recent Developments/Updates
9.5.6 Chandra Bhagat Pharma Competitive Strengths & Weaknesses
9.6 Taj Pharmaceuticals
9.6.1 Taj Pharmaceuticals Details
9.6.2 Taj Pharmaceuticals Major Business
9.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
9.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.6.5 Taj Pharmaceuticals Recent Developments/Updates
9.6.6 Taj Pharmaceuticals Competitive Strengths & Weaknesses
9.7 Endo International
9.7.1 Endo International Details
9.7.2 Endo International Major Business
9.7.3 Endo International Drugs for Schistosomiasis Product and Services
9.7.4 Endo International Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.7.5 Endo International Recent Developments/Updates
9.7.6 Endo International Competitive Strengths & Weaknesses
9.8 Shenyang Hongqi Pharma
9.8.1 Shenyang Hongqi Pharma Details
9.8.2 Shenyang Hongqi Pharma Major Business
9.8.3 Shenyang Hongqi Pharma Drugs for Schistosomiasis Product and Services
9.8.4 Shenyang Hongqi Pharma Drugs for Schistosomiasis Production, Price, Value, Gross Margin and Market Share (2021-2026)
9.8.5 Shenyang Hongqi Pharma Recent Developments/Updates
9.8.6 Shenyang Hongqi Pharma Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Drugs for Schistosomiasis Industry Chain
10.2 Drugs for Schistosomiasis Upstream Analysis
10.2.1 Drugs for Schistosomiasis Core Raw Materials
10.2.2 Main Manufacturers of Drugs for Schistosomiasis Core Raw Materials
10.3 Midstream Analysis
10.4 Downstream Analysis
10.5 Drugs for Schistosomiasis Production Mode
10.6 Drugs for Schistosomiasis Procurement Model
10.7 Drugs for Schistosomiasis Industry Sales Model and Sales Channels
10.7.1 Drugs for Schistosomiasis Sales Model
10.7.2 Drugs for Schistosomiasis Typical Distributors
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Drugs for Schistosomiasis Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Drugs for Schistosomiasis Production Value by Region (2021-2026) & (USD Million)
Table 3. World Drugs for Schistosomiasis Production Value by Region (2027-2032) & (USD Million)
Table 4. World Drugs for Schistosomiasis Production Value Market Share by Region (2021-2026)
Table 5. World Drugs for Schistosomiasis Production Value Market Share by Region (2027-2032)
Table 6. World Drugs for Schistosomiasis Production by Region (2021-2026) & (M Units)
Table 7. World Drugs for Schistosomiasis Production by Region (2027-2032) & (M Units)
Table 8. World Drugs for Schistosomiasis Production Market Share by Region (2021-2026)
Table 9. World Drugs for Schistosomiasis Production Market Share by Region (2027-2032)
Table 10. World Drugs for Schistosomiasis Average Price by Region (2021-2026) & (US$/K Units)
Table 11. World Drugs for Schistosomiasis Average Price by Region (2027-2032) & (US$/K Units)
Table 12. Drugs for Schistosomiasis Major Market Trends
Table 13. World Drugs for Schistosomiasis Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Drugs for Schistosomiasis Consumption by Region (2021-2026) & (M Units)
Table 15. World Drugs for Schistosomiasis Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Drugs for Schistosomiasis Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Drugs for Schistosomiasis Producers in 2025
Table 18. World Drugs for Schistosomiasis Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Drugs for Schistosomiasis Producers in 2025
Table 20. World Drugs for Schistosomiasis Average Price by Manufacturer (2021-2026) & (US$/K Units)
Table 21. Global Drugs for Schistosomiasis Company Evaluation Quadrant
Table 22. World Drugs for Schistosomiasis Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Drugs for Schistosomiasis Production Site of Key Manufacturer
Table 24. Drugs for Schistosomiasis Market: Company Product Type Footprint
Table 25. Drugs for Schistosomiasis Market: Company Product Application Footprint
Table 26. Drugs for Schistosomiasis Competitive Factors
Table 27. Drugs for Schistosomiasis New Entrant and Capacity Expansion Plans
Table 28. Drugs for Schistosomiasis Mergers & Acquisitions Activity
Table 29. United States VS China Drugs for Schistosomiasis Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Drugs for Schistosomiasis Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Drugs for Schistosomiasis Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drugs for Schistosomiasis Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Drugs for Schistosomiasis Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share (2021-2026)
Table 37. China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drugs for Schistosomiasis Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Drugs for Schistosomiasis Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Drugs for Schistosomiasis Production Market Share (2021-2026)
Table 42. Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Drugs for Schistosomiasis Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share (2021-2026)
Table 47. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Drugs for Schistosomiasis Production by Type (2021-2026) & (M Units)
Table 49. World Drugs for Schistosomiasis Production by Type (2027-2032) & (M Units)
Table 50. World Drugs for Schistosomiasis Production Value by Type (2021-2026) & (USD Million)
Table 51. World Drugs for Schistosomiasis Production Value by Type (2027-2032) & (USD Million)
Table 52. World Drugs for Schistosomiasis Average Price by Type (2021-2026) & (US$/K Units)
Table 53. World Drugs for Schistosomiasis Average Price by Type (2027-2032) & (US$/K Units)
Table 54. World Drugs for Schistosomiasis Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Drugs for Schistosomiasis Production by Dosage Form (2021-2026) & (M Units)
Table 56. World Drugs for Schistosomiasis Production by Dosage Form (2027-2032) & (M Units)
Table 57. World Drugs for Schistosomiasis Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Drugs for Schistosomiasis Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Drugs for Schistosomiasis Average Price by Dosage Form (2021-2026) & (US$/K Units)
Table 60. World Drugs for Schistosomiasis Average Price by Dosage Form (2027-2032) & (US$/K Units)
Table 61. World Drugs for Schistosomiasis Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 62. World Drugs for Schistosomiasis Production by End User (2021-2026) & (M Units)
Table 63. World Drugs for Schistosomiasis Production by End User (2027-2032) & (M Units)
Table 64. World Drugs for Schistosomiasis Production Value by End User (2021-2026) & (USD Million)
Table 65. World Drugs for Schistosomiasis Production Value by End User (2027-2032) & (USD Million)
Table 66. World Drugs for Schistosomiasis Average Price by End User (2021-2026) & (US$/K Units)
Table 67. World Drugs for Schistosomiasis Average Price by End User (2027-2032) & (US$/K Units)
Table 68. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Drugs for Schistosomiasis Production by Application (2021-2026) & (M Units)
Table 70. World Drugs for Schistosomiasis Production by Application (2027-2032) & (M Units)
Table 71. World Drugs for Schistosomiasis Production Value by Application (2021-2026) & (USD Million)
Table 72. World Drugs for Schistosomiasis Production Value by Application (2027-2032) & (USD Million)
Table 73. World Drugs for Schistosomiasis Average Price by Application (2021-2026) & (US$/K Units)
Table 74. World Drugs for Schistosomiasis Average Price by Application (2027-2032) & (US$/K Units)
Table 75. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 76. Shin Poong Major Business
Table 77. Shin Poong Drugs for Schistosomiasis Product and Services
Table 78. Shin Poong Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Shin Poong Recent Developments/Updates
Table 80. Shin Poong Competitive Strengths & Weaknesses
Table 81. Merck Basic Information, Manufacturing Base and Competitors
Table 82. Merck Major Business
Table 83. Merck Drugs for Schistosomiasis Product and Services
Table 84. Merck Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Recent Developments/Updates
Table 86. Merck Competitive Strengths & Weaknesses
Table 87. Bayer Basic Information, Manufacturing Base and Competitors
Table 88. Bayer Major Business
Table 89. Bayer Drugs for Schistosomiasis Product and Services
Table 90. Bayer Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bayer Recent Developments/Updates
Table 92. Bayer Competitive Strengths & Weaknesses
Table 93. EIPICO Basic Information, Manufacturing Base and Competitors
Table 94. EIPICO Major Business
Table 95. EIPICO Drugs for Schistosomiasis Product and Services
Table 96. EIPICO Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. EIPICO Recent Developments/Updates
Table 98. EIPICO Competitive Strengths & Weaknesses
Table 99. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Chandra Bhagat Pharma Major Business
Table 101. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 102. Chandra Bhagat Pharma Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Chandra Bhagat Pharma Recent Developments/Updates
Table 104. Chandra Bhagat Pharma Competitive Strengths & Weaknesses
Table 105. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 106. Taj Pharmaceuticals Major Business
Table 107. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 108. Taj Pharmaceuticals Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 111. Endo International Basic Information, Manufacturing Base and Competitors
Table 112. Endo International Major Business
Table 113. Endo International Drugs for Schistosomiasis Product and Services
Table 114. Endo International Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Endo International Recent Developments/Updates
Table 116. Endo International Competitive Strengths & Weaknesses
Table 117. Shenyang Hongqi Pharma Basic Information, Manufacturing Base and Competitors
Table 118. Shenyang Hongqi Pharma Major Business
Table 119. Shenyang Hongqi Pharma Drugs for Schistosomiasis Product and Services
Table 120. Shenyang Hongqi Pharma Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Shenyang Hongqi Pharma Recent Developments/Updates
Table 122. Shenyang Hongqi Pharma Competitive Strengths & Weaknesses
Table 123. Global Key Players of Drugs for Schistosomiasis Upstream (Raw Materials)
Table 124. Global Drugs for Schistosomiasis Typical Customers
Table 125. Drugs for Schistosomiasis Typical Distributors
Table 1. World Drugs for Schistosomiasis Production Value by Region (2021, 2025 and 2032) & (USD Million)
Table 2. World Drugs for Schistosomiasis Production Value by Region (2021-2026) & (USD Million)
Table 3. World Drugs for Schistosomiasis Production Value by Region (2027-2032) & (USD Million)
Table 4. World Drugs for Schistosomiasis Production Value Market Share by Region (2021-2026)
Table 5. World Drugs for Schistosomiasis Production Value Market Share by Region (2027-2032)
Table 6. World Drugs for Schistosomiasis Production by Region (2021-2026) & (M Units)
Table 7. World Drugs for Schistosomiasis Production by Region (2027-2032) & (M Units)
Table 8. World Drugs for Schistosomiasis Production Market Share by Region (2021-2026)
Table 9. World Drugs for Schistosomiasis Production Market Share by Region (2027-2032)
Table 10. World Drugs for Schistosomiasis Average Price by Region (2021-2026) & (US$/K Units)
Table 11. World Drugs for Schistosomiasis Average Price by Region (2027-2032) & (US$/K Units)
Table 12. Drugs for Schistosomiasis Major Market Trends
Table 13. World Drugs for Schistosomiasis Consumption Growth Rate Forecast by Region (2021 & 2025 & 2032) & (M Units)
Table 14. World Drugs for Schistosomiasis Consumption by Region (2021-2026) & (M Units)
Table 15. World Drugs for Schistosomiasis Consumption Forecast by Region (2027-2032) & (M Units)
Table 16. World Drugs for Schistosomiasis Production Value by Manufacturer (2021-2026) & (USD Million)
Table 17. Production Value Market Share of Key Drugs for Schistosomiasis Producers in 2025
Table 18. World Drugs for Schistosomiasis Production by Manufacturer (2021-2026) & (M Units)
Table 19. Production Market Share of Key Drugs for Schistosomiasis Producers in 2025
Table 20. World Drugs for Schistosomiasis Average Price by Manufacturer (2021-2026) & (US$/K Units)
Table 21. Global Drugs for Schistosomiasis Company Evaluation Quadrant
Table 22. World Drugs for Schistosomiasis Industry Rank of Major Manufacturers, Based on Production Value in 2025
Table 23. Head Office and Drugs for Schistosomiasis Production Site of Key Manufacturer
Table 24. Drugs for Schistosomiasis Market: Company Product Type Footprint
Table 25. Drugs for Schistosomiasis Market: Company Product Application Footprint
Table 26. Drugs for Schistosomiasis Competitive Factors
Table 27. Drugs for Schistosomiasis New Entrant and Capacity Expansion Plans
Table 28. Drugs for Schistosomiasis Mergers & Acquisitions Activity
Table 29. United States VS China Drugs for Schistosomiasis Production Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 30. United States VS China Drugs for Schistosomiasis Production Comparison, (2021 & 2025 & 2032) & (M Units)
Table 31. United States VS China Drugs for Schistosomiasis Consumption Comparison, (2021 & 2025 & 2032) & (M Units)
Table 32. United States Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Drugs for Schistosomiasis Production Value, (2021-2026) & (USD Million)
Table 34. United States Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2021-2026)
Table 35. United States Based Manufacturers Drugs for Schistosomiasis Production (2021-2026) & (M Units)
Table 36. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share (2021-2026)
Table 37. China Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Drugs for Schistosomiasis Production Value, (2021-2026) & (USD Million)
Table 39. China Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2021-2026)
Table 40. China Based Manufacturers Drugs for Schistosomiasis Production, (2021-2026) & (M Units)
Table 41. China Based Manufacturers Drugs for Schistosomiasis Production Market Share (2021-2026)
Table 42. Rest of World Based Drugs for Schistosomiasis Manufacturers, Headquarters and Production Site (State, Country)
Table 43. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value, (2021-2026) & (USD Million)
Table 44. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Value Market Share (2021-2026)
Table 45. Rest of World Based Manufacturers Drugs for Schistosomiasis Production, (2021-2026) & (M Units)
Table 46. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share (2021-2026)
Table 47. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2021 & 2025 & 2032
Table 48. World Drugs for Schistosomiasis Production by Type (2021-2026) & (M Units)
Table 49. World Drugs for Schistosomiasis Production by Type (2027-2032) & (M Units)
Table 50. World Drugs for Schistosomiasis Production Value by Type (2021-2026) & (USD Million)
Table 51. World Drugs for Schistosomiasis Production Value by Type (2027-2032) & (USD Million)
Table 52. World Drugs for Schistosomiasis Average Price by Type (2021-2026) & (US$/K Units)
Table 53. World Drugs for Schistosomiasis Average Price by Type (2027-2032) & (US$/K Units)
Table 54. World Drugs for Schistosomiasis Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Table 55. World Drugs for Schistosomiasis Production by Dosage Form (2021-2026) & (M Units)
Table 56. World Drugs for Schistosomiasis Production by Dosage Form (2027-2032) & (M Units)
Table 57. World Drugs for Schistosomiasis Production Value by Dosage Form (2021-2026) & (USD Million)
Table 58. World Drugs for Schistosomiasis Production Value by Dosage Form (2027-2032) & (USD Million)
Table 59. World Drugs for Schistosomiasis Average Price by Dosage Form (2021-2026) & (US$/K Units)
Table 60. World Drugs for Schistosomiasis Average Price by Dosage Form (2027-2032) & (US$/K Units)
Table 61. World Drugs for Schistosomiasis Production Value by End User, (USD Million), 2021 & 2025 & 2032
Table 62. World Drugs for Schistosomiasis Production by End User (2021-2026) & (M Units)
Table 63. World Drugs for Schistosomiasis Production by End User (2027-2032) & (M Units)
Table 64. World Drugs for Schistosomiasis Production Value by End User (2021-2026) & (USD Million)
Table 65. World Drugs for Schistosomiasis Production Value by End User (2027-2032) & (USD Million)
Table 66. World Drugs for Schistosomiasis Average Price by End User (2021-2026) & (US$/K Units)
Table 67. World Drugs for Schistosomiasis Average Price by End User (2027-2032) & (US$/K Units)
Table 68. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2021 & 2025 & 2032
Table 69. World Drugs for Schistosomiasis Production by Application (2021-2026) & (M Units)
Table 70. World Drugs for Schistosomiasis Production by Application (2027-2032) & (M Units)
Table 71. World Drugs for Schistosomiasis Production Value by Application (2021-2026) & (USD Million)
Table 72. World Drugs for Schistosomiasis Production Value by Application (2027-2032) & (USD Million)
Table 73. World Drugs for Schistosomiasis Average Price by Application (2021-2026) & (US$/K Units)
Table 74. World Drugs for Schistosomiasis Average Price by Application (2027-2032) & (US$/K Units)
Table 75. Shin Poong Basic Information, Manufacturing Base and Competitors
Table 76. Shin Poong Major Business
Table 77. Shin Poong Drugs for Schistosomiasis Product and Services
Table 78. Shin Poong Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. Shin Poong Recent Developments/Updates
Table 80. Shin Poong Competitive Strengths & Weaknesses
Table 81. Merck Basic Information, Manufacturing Base and Competitors
Table 82. Merck Major Business
Table 83. Merck Drugs for Schistosomiasis Product and Services
Table 84. Merck Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Merck Recent Developments/Updates
Table 86. Merck Competitive Strengths & Weaknesses
Table 87. Bayer Basic Information, Manufacturing Base and Competitors
Table 88. Bayer Major Business
Table 89. Bayer Drugs for Schistosomiasis Product and Services
Table 90. Bayer Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 91. Bayer Recent Developments/Updates
Table 92. Bayer Competitive Strengths & Weaknesses
Table 93. EIPICO Basic Information, Manufacturing Base and Competitors
Table 94. EIPICO Major Business
Table 95. EIPICO Drugs for Schistosomiasis Product and Services
Table 96. EIPICO Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 97. EIPICO Recent Developments/Updates
Table 98. EIPICO Competitive Strengths & Weaknesses
Table 99. Chandra Bhagat Pharma Basic Information, Manufacturing Base and Competitors
Table 100. Chandra Bhagat Pharma Major Business
Table 101. Chandra Bhagat Pharma Drugs for Schistosomiasis Product and Services
Table 102. Chandra Bhagat Pharma Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 103. Chandra Bhagat Pharma Recent Developments/Updates
Table 104. Chandra Bhagat Pharma Competitive Strengths & Weaknesses
Table 105. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 106. Taj Pharmaceuticals Major Business
Table 107. Taj Pharmaceuticals Drugs for Schistosomiasis Product and Services
Table 108. Taj Pharmaceuticals Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Taj Pharmaceuticals Recent Developments/Updates
Table 110. Taj Pharmaceuticals Competitive Strengths & Weaknesses
Table 111. Endo International Basic Information, Manufacturing Base and Competitors
Table 112. Endo International Major Business
Table 113. Endo International Drugs for Schistosomiasis Product and Services
Table 114. Endo International Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. Endo International Recent Developments/Updates
Table 116. Endo International Competitive Strengths & Weaknesses
Table 117. Shenyang Hongqi Pharma Basic Information, Manufacturing Base and Competitors
Table 118. Shenyang Hongqi Pharma Major Business
Table 119. Shenyang Hongqi Pharma Drugs for Schistosomiasis Product and Services
Table 120. Shenyang Hongqi Pharma Drugs for Schistosomiasis Production (M Units), Price (US$/K Units), Production Value (USD Million), Gross Margin and Market Share (2021-2026)
Table 121. Shenyang Hongqi Pharma Recent Developments/Updates
Table 122. Shenyang Hongqi Pharma Competitive Strengths & Weaknesses
Table 123. Global Key Players of Drugs for Schistosomiasis Upstream (Raw Materials)
Table 124. Global Drugs for Schistosomiasis Typical Customers
Table 125. Drugs for Schistosomiasis Typical Distributors
LIST OF FIGURES
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. World Drugs for Schistosomiasis Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drugs for Schistosomiasis Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 5. World Drugs for Schistosomiasis Average Price (2021-2032) & (US$/K Units)
Figure 6. World Drugs for Schistosomiasis Production Value Market Share by Region (2021-2032)
Figure 7. World Drugs for Schistosomiasis Production Market Share by Region (2021-2032)
Figure 8. North America Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 9. Europe Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 10. China Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 11. Japan Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 12. India Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 13. South Korea Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 14. Drugs for Schistosomiasis Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 17. World Drugs for Schistosomiasis Consumption Market Share by Region (2021-2032)
Figure 18. United States Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 19. China Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 20. Europe Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 21. Japan Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 22. South Korea Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 23. ASEAN Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 24. India Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 25. Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Drugs for Schistosomiasis Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Drugs for Schistosomiasis Markets in 2025
Figure 28. United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share 2025
Figure 32. China Based Manufacturers Drugs for Schistosomiasis Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share 2025
Figure 34. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Drugs for Schistosomiasis Production Value Market Share by Type in 2025
Figure 36. Praziquantel
Figure 37. Oxamniquine
Figure 38. Other
Figure 39. World Drugs for Schistosomiasis Production Market Share by Type (2021-2032)
Figure 40. World Drugs for Schistosomiasis Production Value Market Share by Type (2021-2032)
Figure 41. World Drugs for Schistosomiasis Average Price by Type (2021-2032) & (US$/K Units)
Figure 42. World Drugs for Schistosomiasis Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 43. World Drugs for Schistosomiasis Production Value Market Share by Dosage Form in 2025
Figure 44. OralTablets
Figure 45. Oral Suspension
Figure 46. Injectable Form
Figure 47. Other
Figure 48. World Drugs for Schistosomiasis Production Market Share by Dosage Form (2021-2032)
Figure 49. World Drugs for Schistosomiasis Production Value Market Share by Dosage Form (2021-2032)
Figure 50. World Drugs for Schistosomiasis Average Price by Dosage Form (2021-2032) & (US$/K Units)
Figure 51. World Drugs for Schistosomiasis Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 52. World Drugs for Schistosomiasis Production Value Market Share by End User in 2025
Figure 53. Hospitals Use
Figure 54. Pediatric Use
Figure 55. NGO Programs
Figure 56. World Drugs for Schistosomiasis Production Market Share by End User (2021-2032)
Figure 57. World Drugs for Schistosomiasis Production Value Market Share by End User (2021-2032)
Figure 58. World Drugs for Schistosomiasis Average Price by End User (2021-2032) & (US$/K Units)
Figure 59. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 60. World Drugs for Schistosomiasis Production Value Market Share by Application in 2025
Figure 61. S. haematobium
Figure 62. S. mansoni
Figure 63. S. japonicum
Figure 64. S. mekongi
Figure 65. S. intercalatum
Figure 66. World Drugs for Schistosomiasis Production Market Share by Application (2021-2032)
Figure 67. World Drugs for Schistosomiasis Production Value Market Share by Application (2021-2032)
Figure 68. World Drugs for Schistosomiasis Average Price by Application (2021-2032) & (US$/K Units)
Figure 69. Drugs for Schistosomiasis Industry Chain
Figure 70. Drugs for Schistosomiasis Procurement Model
Figure 71. Drugs for Schistosomiasis Sales Model
Figure 72. Drugs for Schistosomiasis Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Drugs for Schistosomiasis Picture
Figure 2. World Drugs for Schistosomiasis Production Value: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Drugs for Schistosomiasis Production Value and Forecast (2021-2032) & (USD Million)
Figure 4. World Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 5. World Drugs for Schistosomiasis Average Price (2021-2032) & (US$/K Units)
Figure 6. World Drugs for Schistosomiasis Production Value Market Share by Region (2021-2032)
Figure 7. World Drugs for Schistosomiasis Production Market Share by Region (2021-2032)
Figure 8. North America Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 9. Europe Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 10. China Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 11. Japan Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 12. India Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 13. South Korea Drugs for Schistosomiasis Production (2021-2032) & (M Units)
Figure 14. Drugs for Schistosomiasis Market Drivers
Figure 15. Factors Affecting Demand
Figure 16. World Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 17. World Drugs for Schistosomiasis Consumption Market Share by Region (2021-2032)
Figure 18. United States Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 19. China Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 20. Europe Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 21. Japan Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 22. South Korea Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 23. ASEAN Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 24. India Drugs for Schistosomiasis Consumption (2021-2032) & (M Units)
Figure 25. Producer Shipments of Drugs for Schistosomiasis by Manufacturer Revenue ($MM) and Market Share (%): 2025
Figure 26. Global Four-firm Concentration Ratios (CR4) for Drugs for Schistosomiasis Markets in 2025
Figure 27. Global Four-firm Concentration Ratios (CR8) for Drugs for Schistosomiasis Markets in 2025
Figure 28. United States VS China: Drugs for Schistosomiasis Production Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. United States VS China: Drugs for Schistosomiasis Production Market Share Comparison (2021 & 2025 & 2032)
Figure 30. United States VS China: Drugs for Schistosomiasis Consumption Market Share Comparison (2021 & 2025 & 2032)
Figure 31. United States Based Manufacturers Drugs for Schistosomiasis Production Market Share 2025
Figure 32. China Based Manufacturers Drugs for Schistosomiasis Production Market Share 2025
Figure 33. Rest of World Based Manufacturers Drugs for Schistosomiasis Production Market Share 2025
Figure 34. World Drugs for Schistosomiasis Production Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 35. World Drugs for Schistosomiasis Production Value Market Share by Type in 2025
Figure 36. Praziquantel
Figure 37. Oxamniquine
Figure 38. Other
Figure 39. World Drugs for Schistosomiasis Production Market Share by Type (2021-2032)
Figure 40. World Drugs for Schistosomiasis Production Value Market Share by Type (2021-2032)
Figure 41. World Drugs for Schistosomiasis Average Price by Type (2021-2032) & (US$/K Units)
Figure 42. World Drugs for Schistosomiasis Production Value by Dosage Form, (USD Million), 2021 & 2025 & 2032
Figure 43. World Drugs for Schistosomiasis Production Value Market Share by Dosage Form in 2025
Figure 44. OralTablets
Figure 45. Oral Suspension
Figure 46. Injectable Form
Figure 47. Other
Figure 48. World Drugs for Schistosomiasis Production Market Share by Dosage Form (2021-2032)
Figure 49. World Drugs for Schistosomiasis Production Value Market Share by Dosage Form (2021-2032)
Figure 50. World Drugs for Schistosomiasis Average Price by Dosage Form (2021-2032) & (US$/K Units)
Figure 51. World Drugs for Schistosomiasis Production Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 52. World Drugs for Schistosomiasis Production Value Market Share by End User in 2025
Figure 53. Hospitals Use
Figure 54. Pediatric Use
Figure 55. NGO Programs
Figure 56. World Drugs for Schistosomiasis Production Market Share by End User (2021-2032)
Figure 57. World Drugs for Schistosomiasis Production Value Market Share by End User (2021-2032)
Figure 58. World Drugs for Schistosomiasis Average Price by End User (2021-2032) & (US$/K Units)
Figure 59. World Drugs for Schistosomiasis Production Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 60. World Drugs for Schistosomiasis Production Value Market Share by Application in 2025
Figure 61. S. haematobium
Figure 62. S. mansoni
Figure 63. S. japonicum
Figure 64. S. mekongi
Figure 65. S. intercalatum
Figure 66. World Drugs for Schistosomiasis Production Market Share by Application (2021-2032)
Figure 67. World Drugs for Schistosomiasis Production Value Market Share by Application (2021-2032)
Figure 68. World Drugs for Schistosomiasis Average Price by Application (2021-2032) & (US$/K Units)
Figure 69. Drugs for Schistosomiasis Industry Chain
Figure 70. Drugs for Schistosomiasis Procurement Model
Figure 71. Drugs for Schistosomiasis Sales Model
Figure 72. Drugs for Schistosomiasis Sales Channels, Direct Sales, and Distribution
Figure 73. Methodology
Figure 74. Research Process and Data Source
